Recent Updates
Recently added Catalysts
EBS Positive Sentiment Score: 70/100

Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Key Takeaway: Emergent BioSolutions Inc. has announced that CEO Joe Papa will present at the 44th Annual J.P. Morgan Healthcare Conference scheduled for January 14, 2026. The presentation will take place at 5:15 PM PST, and an audio link will be available for up to 30 days. Additionally, the presentation slides will be accessible on the company's Investor section at the time of the presentation.

Market Sentiment Analysis

POSITIVE FACTORS

  • Emergent BioSolutions is presenting at a prestigious healthcare conference.
  • CEO Joe Papa is actively participating and representing the company.
  • The presentation showcases the company's initiative and engagement with investors.

Full Press Release Details

GAITHERSBURG, Md., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that Joe Papa, president and chief executive officer, will provide a company presentation during the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 5:15 PM PST.
The audio link for Emergent’s session may be accessed here and will be live for up to 30 days.
The Company’s slides will be made available at the time of the presentation on the Investors section of the Emergent website.
About Emergent BioSolutions
Executive Vice President, CFO
Vice President, Communications

Frequently Asked Questions

When will Emergent BioSolutions present at the J.P. Morgan Conference?

Emergent BioSolutions will present on January 14, 2026, at 5:15 PM PST.

Where can I find the presentation slides for Emergent's session?

The presentation slides will be available on the Investors section of Emergent's website.

How long will the audio link for the presentation be available?

The audio link for the presentation will be accessible for up to 30 days.

Who is the CEO of Emergent BioSolutions?

Joe Papa is the president and chief executive officer of Emergent BioSolutions.

Last updated: Jan 7, 2026